300122 智飞生物
已收盘 02-28 15:00:00
资讯
新帖
简况
智飞生物:全资子公司智飞绿竹研发的组分百白破-Hib四联疫苗升级了百日咳抗原纯化及配制工艺
证券之星 · 02-28 10:00
智飞生物:全资子公司智飞绿竹研发的组分百白破-Hib四联疫苗升级了百日咳抗原纯化及配制工艺
智飞生物(300122.SZ):组分百白破-Hib四联疫苗临床试验申请获得受理
智通财经 · 02-21
智飞生物(300122.SZ):组分百白破-Hib四联疫苗临床试验申请获得受理
智飞生物最新公告:吸附无细胞百白破(组分)b型流感嗜血杆菌(结合)联合疫苗临床试验申请获得受理
证券之星 · 02-21
智飞生物最新公告:吸附无细胞百白破(组分)b型流感嗜血杆菌(结合)联合疫苗临床试验申请获得受理
每周股票复盘:智飞生物(300122)出现折价大宗交易
证券之星 · 02-14
每周股票复盘:智飞生物(300122)出现折价大宗交易
智飞生物:公司正在推进对宸安生物的整合工作
证券之星 · 02-14
智飞生物:公司正在推进对宸安生物的整合工作
2月12日智飞生物现1笔折价20.44%的大宗交易 合计成交645.12万元
证券之星 · 02-12
2月12日智飞生物现1笔折价20.44%的大宗交易 合计成交645.12万元
智飞生物2月12日现1笔大宗交易 成交金额645.12万元
新浪证券-红岸工作室 · 02-12
智飞生物2月12日现1笔大宗交易 成交金额645.12万元
智飞生物:截至2025年1月27日,公司普通股股东人数为123312
证券之星 · 02-08
智飞生物:截至2025年1月27日,公司普通股股东人数为123312
智飞生物:公司始终贯彻可持续发展理念,积极落实绿色运营管理措施
金融界 · 02-08
智飞生物:公司始终贯彻可持续发展理念,积极落实绿色运营管理措施
智飞生物收盘上涨3.04%,滚动市盈率16.48倍,总市值608.02亿元
金融界 · 02-07
智飞生物收盘上涨3.04%,滚动市盈率16.48倍,总市值608.02亿元
万泰生物、智飞生物、沃森生物业绩增长失速,默沙东暂停供货 HPV疫苗故事画上休止符
每日经济新闻 · 02-05
万泰生物、智飞生物、沃森生物业绩增长失速,默沙东暂停供货 HPV疫苗故事画上休止符
暂停HPV疫苗中国市场供应?默沙东:预计年中逐步恢复常态
美港电讯 · 02-05
暂停HPV疫苗中国市场供应?默沙东:预计年中逐步恢复常态
暂停向中国发货HPV疫苗?默沙东回应
美港电讯 · 02-05
暂停向中国发货HPV疫苗?默沙东回应
智飞生物(300122)1月20日股东户数12.47万户,较上期减少3.19%
证券之星 · 01-27
智飞生物(300122)1月20日股东户数12.47万户,较上期减少3.19%
智飞生物:截至2025年1月20日,公司普通股股东人数为124,674
证券之星 · 01-27
智飞生物:截至2025年1月20日,公司普通股股东人数为124,674
智飞生物(300122.SZ)发预减,预计2024年度净利润18.56亿元–26.63亿元,同比下降67%-77%
智通财经 · 01-24
智飞生物(300122.SZ)发预减,预计2024年度净利润18.56亿元–26.63亿元,同比下降67%-77%
智飞生物:预计2024年全年扣非后净利润盈利18.21亿元至26.12亿元
证券之星 · 01-24
智飞生物:预计2024年全年扣非后净利润盈利18.21亿元至26.12亿元
智飞生物最新公告:预计2024年净利润同比下降67%-77%
证券之星 · 01-24
智飞生物最新公告:预计2024年净利润同比下降67%-77%
智飞生物:公司截至2024年12月31日的股东人数及其详情请关注并查阅公司定期报告披露的相关内容
证券之星 · 01-10
智飞生物:公司截至2024年12月31日的股东人数及其详情请关注并查阅公司定期报告披露的相关内容
智飞生物:公司的员工持股计划在正常存续中
互动易 · 01-10
智飞生物:公司的员工持股计划在正常存续中
加载更多
公司概况
公司名称:
重庆智飞生物制品股份有限公司
所属行业:
医药制造业
上市日期:
2010-09-28
主营业务:
重庆智飞生物制品股份有限公司是一家从事疫苗、生物制品的研发、生产和销售的公司;公司的主要产品包括预防流脑、宫颈癌、肺炎、轮状病毒等传染病的疫苗产品,也涵盖提供结核感染诊断、预防、治疗有效解决方案的药品。公司自成立以来,一贯注重研发与技术创新,通过十余年稳步增长的研发投入和持续深入的研发活动,形成了行业较领先的研发技术能力,并为公司可持续发展提供了技术根基。先后参与了科技部“863计划”,“现代医学技术”项目,科技部重大新药创制,国家新药创制重大专项等20余项国家级,省部级项目。
发行价格:
37.98
{"stockData":{"symbol":"300122","market":"SZ","secType":"STK","nameCN":"智飞生物","latestPrice":25.1,"timestamp":1740726192000,"preClose":26.01,"halted":0,"volume":26035961,"delay":0,"changeRate":-0.035,"floatShares":1414000000,"shares":2394000000,"eps":1.5416,"marketStatus":"已收盘","change":-0.91,"latestTime":"02-28 15:00:00","open":25.9,"high":26.17,"low":24.89,"amount":662000000,"amplitude":0.0492,"askPrice":25.1,"askSize":2,"bidPrice":25.08,"bidSize":22,"shortable":0,"etf":0,"ttmEps":1.5416,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1740965400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.01,"symbolType":"stock","openAndCloseTimeList":[[1740706200000,1740713400000],[1740718800000,1740726000000]],"highLimit":28.61,"lowLimit":23.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2393789747,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":16.281785,"roe":"6.78%","epsLYR":3.3624,"committee":-0.088889,"marketValue":60084000000,"turnoverRate":0.0184,"status":1,"floatMarketCap":35499000000},"requestUrl":"/m/hq/s/300122","defaultTab":"news","newsList":[{"id":"2514224349","title":"智飞生物:全资子公司智飞绿竹研发的组分百白破-Hib四联疫苗升级了百日咳抗原纯化及配制工艺","url":"https://stock-news.laohu8.com/highlight/detail?id=2514224349","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514224349?lang=zh_cn&edition=full","pubTime":"2025-02-28 18:00","pubTimestamp":1740736820,"startTime":"0","endTime":"0","summary":"智飞生物董秘:您好,国内有1款无细胞百白破b型流感嗜血杆菌联合疫苗上市销售,采用共纯化技术制备。由公司全资子公司智飞绿竹研发的组分百白破-Hib四联疫苗,百日咳升级了百日咳抗原纯化及配制工艺,系采用三个单独纯化的百日咳有效抗原组分联合白喉、破伤风、Hib有效组分配制的质量均一的疫苗产品。智飞生物股价下跌了好几年,请问是否有退市风险警示!二级市场股价的变化受多种因素影响,公司目前生产经营正常。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800033722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","159646","BK0188","LU1328615791.USD","BK0196","BK0046","BK0239","LU1064130708.USD","300122","LU2148510915.USD","LU2580892862.HKD","BK0077","LU1064131003.USD"],"gpt_icon":0},{"id":"2513862261","title":"智飞生物(300122.SZ):组分百白破-Hib四联疫苗临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2513862261","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513862261?lang=zh_cn&edition=full","pubTime":"2025-02-21 19:55","pubTimestamp":1740138913,"startTime":"0","endTime":"0","summary":"智通财经APP讯,智飞生物 发布公告,公司于近日获悉,由全资子公司北京智飞绿竹生物制药有限公司研发的吸附无细胞百白破(组分)b型流感嗜血杆菌(结合)联合疫苗获得国家药品监督管理局药物临床试验申请受理通知书。截至目前,经查询国家药品监督管理局网站,国内有1款无细胞百白破b型流感嗜血杆菌联合疫苗上市销售,采用共纯化技术制备。目前,国内暂无组分百白破-Hib四联疫苗获批上市,市场前景广阔。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1583","159646","BK0196","LU1064130708.USD","LU2580892789.USD","BK1141","LU2148510915.USD","LU2580892862.HKD","300122","BK1576","BK0046","BK0188","BK0239","LU1064131003.USD","BK0077","LU1328615791.USD"],"gpt_icon":0},{"id":"2513426501","title":"智飞生物最新公告:吸附无细胞百白破(组分)b型流感嗜血杆菌(结合)联合疫苗临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2513426501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513426501?lang=zh_cn&edition=full","pubTime":"2025-02-21 19:09","pubTimestamp":1740136173,"startTime":"0","endTime":"0","summary":"智飞生物公告称,公司全资子公司智飞绿竹研发的组分百白破-Hib四联疫苗获得国家药品监督管理局药物临床试验申请受理通知书。该疫苗可预防由百日咳、白喉、破伤风以及Hib感染引起疾病,减少接种针次,增强预防接种的依从性。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100037081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","300122","LU1064131003.USD","BK0239","LU2580892862.HKD","BK1141","BK0188","BK1583","LU1064130708.USD","BK0077","BK0046","BK0196","LU2148510915.USD","LU2580892789.USD","BK1576","LU1328615791.USD"],"gpt_icon":0},{"id":"2511861229","title":"每周股票复盘:智飞生物(300122)出现折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2511861229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511861229?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:50","pubTimestamp":1739566216,"startTime":"0","endTime":"0","summary":"截至2025年2月14日收盘,智飞生物报收于25.49元,较上周的25.4元上涨0.35%。本周,智飞生物2月10日盘中最高价报25.83元。智飞生物当前最新总市值610.18亿元,在生物制品板块市值排名2/50,在两市A股市值排名231/5130。本周关注点交易信息汇总: 2月12日智飞生物出现一笔折价20.44%的大宗交易,合计成交645.12万元交易信息汇总2月12日智飞生物出现一笔折价20.44%的大宗交易,合计成交金额为645.12万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500008854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","LU1328615791.USD","BK0188","BK0196","BK0046","BK0239","LU1064130708.USD","300122","LU2148510915.USD","LU2580892862.HKD","BK0077","LU1064131003.USD"],"gpt_icon":0},{"id":"2511663410","title":"智飞生物:公司正在推进对宸安生物的整合工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511663410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511663410?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:30","pubTimestamp":1739529015,"startTime":"0","endTime":"0","summary":"智飞生物董秘:您好,公司一直以来坚持深耕主业,通过“技术&市场”双轮驱动战略持续提升公司核心竞争力,促进公司高质量发展,与此同时,公司始终严格按照法律法规要求履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400033033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","300122","LU2148510915.USD","LU1064131003.USD","LU2580892862.HKD","BK0077","BK0239","BK0046","LU1328615791.USD","BK0196","LU1064130708.USD","BK0188"],"gpt_icon":0},{"id":"2510328295","title":"2月12日智飞生物现1笔折价20.44%的大宗交易 合计成交645.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510328295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510328295?lang=zh_cn&edition=full","pubTime":"2025-02-12 17:03","pubTimestamp":1739351011,"startTime":"0","endTime":"0","summary":"证券之星消息,2月12日智飞生物发生大宗交易,交易数据如下:大宗交易成交价格20.16元,相对当日收盘价折价20.44%,成交32万股,成交金额645.12万元,买方营业部为中国银河证券股份有限公司太原桃园证券营业部,卖方营业部为国金证券股份有限公司上海静安区南京西路证券营业部。近三个月该股共发生1笔大宗交易,合计成交3200.0手,折价成交1笔。截至2025年2月12日收盘,智飞生物报收于25.34元,上涨0.56%,换手率1.35%,成交量19.11万手,成交额4.79亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021200027289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","LU2580892862.HKD","BK0077","BK0196","300122","LU1064130708.USD","BK0188","LU2580892789.USD","LU1064131003.USD","BK0046","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2510237443","title":"智飞生物2月12日现1笔大宗交易 成交金额645.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510237443","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510237443?lang=zh_cn&edition=full","pubTime":"2025-02-12 17:00","pubTimestamp":1739350800,"startTime":"0","endTime":"0","summary":" 2月12日,智飞生物收涨0.56%,收盘价为25.34元,发生1笔大宗交易,合计成交量32万股,成交金额645.12万元。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为645.12万元。该股近5个交易日累计上涨4.32%,主力资金合计净流出3633.23万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-02-12/doc-inekfnky1627887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1064130708.USD","300122","BK0046","LU2580892862.HKD","LU1328615791.USD","LU1064131003.USD","BK0077","BK0196","BK0188","LU2580892789.USD","BK0239","LU2148510915.USD"],"gpt_icon":0},{"id":"2509036936","title":"智飞生物:截至2025年1月27日,公司普通股股东人数为123312","url":"https://stock-news.laohu8.com/highlight/detail?id=2509036936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509036936?lang=zh_cn&edition=full","pubTime":"2025-02-08 18:00","pubTimestamp":1739008837,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物02月08日在投资者关系平台上答复投资者关心的问题。投资者:请问截止25年1月底的股东人数,谢谢智飞生物董秘:您好,截至2025年1月27日,公司普通股股东人数为123312,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020800059297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","LU1328615791.USD","BK0188","BK0196","BK0046","BK0239","LU1064130708.USD","300122","LU2148510915.USD","LU2580892862.HKD","BK0077","LU1064131003.USD"],"gpt_icon":0},{"id":"2509390033","title":"智飞生物:公司始终贯彻可持续发展理念,积极落实绿色运营管理措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2509390033","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509390033?lang=zh_cn&edition=full","pubTime":"2025-02-08 16:48","pubTimestamp":1739004514,"startTime":"0","endTime":"0","summary":"金融界2月8日消息,有投资者在互动平台向智飞生物提问:您好,我是一名市民,一直很关注空气质量问题。想请问贵公司有没有为防范空气污染采取一些措施?我们居民都希望生活在一个空气清新的城市里,期待贵公司能在其中发挥积极作用。公司回答表示:公司始终贯彻“社会效益第一,企业效益第二”的经营宗旨,秉持可持续发展的理念,贯彻落实安全生产、环保节约的管理要求,将低碳、循环、减排、安全融入日常运营管理的每一个环节,严格落实节能减排、绿色运营等管理举措,打造绿色环保型企业,助力社会可持续发展。\n\n\r\n 责任编辑:小讯","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/08164848034561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1064131003.USD","LU2148510915.USD","LU2580892789.USD","BK0239","300122","LU1064130708.USD","BK0046","BK0188","BK0196","LU2580892862.HKD","LU1328615791.USD","BK0077"],"gpt_icon":0},{"id":"2509992217","title":"智飞生物收盘上涨3.04%,滚动市盈率16.48倍,总市值608.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509992217","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509992217?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:23","pubTimestamp":1738916628,"startTime":"0","endTime":"0","summary":"2月7日,智飞生物今日收盘25.4元,上涨3.04%,滚动市盈率PE达到16.48倍,创19天以来新低,总市值608.02亿元。从行业市盈率排名来看,公司所处的生物制品行业市盈率平均34.06倍,行业中值33.95倍,智飞生物排名第34位。资金流向方面,2月7日,智飞生物主力资金净流入1800.45万元,近5日总体呈流出状态,5日共流出1470.40万元。最新一期业绩显示,2024年三季报,公司实现营业收入227.86亿元,同比-41.98%;净利润21.51亿元,同比-67.07%,销售毛利率27.23%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/07162348013097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0196","LU1064130708.USD","LU2580892789.USD","LU2148510915.USD","LU2580892862.HKD","300122","BK0046","BK0188","BK0239","LU1064131003.USD","BK0077","LU1328615791.USD"],"gpt_icon":0},{"id":"2509040284","title":"万泰生物、智飞生物、沃森生物业绩增长失速,默沙东暂停供货 HPV疫苗故事画上休止符","url":"https://stock-news.laohu8.com/highlight/detail?id=2509040284","media":"每日经济新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509040284?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:37","pubTimestamp":1738766235,"startTime":"0","endTime":"0","summary":"近期,三家均以HPV疫苗作为代表产品的公司——万泰生物、沃森生物、智飞生物,纷纷发布2024年业绩预告,且业绩均有大幅度同比下滑。另一端,默沙东方面于2月4日表示,与智飞生物商议后,将暂停向中国市场供应HPV疫苗直至本年年中。九价HPV疫苗同样告别高增长作为HPV疫苗的代表企业,万泰生物和沃森生物业绩下滑并不令人意外。就在2月4日,作为智飞生物HPV疫苗的供应商,默沙东宣布将从今年2月至年中暂停向中国供应HPV疫苗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223742abc37f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223742abc37f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0046","BK0070","BK0239","159646","LU1064130708.USD","LU1064131003.USD","603392","LU2580892789.USD","LU2148510915.USD","LU2580892862.HKD","LU1328615791.USD","300142","300122","BK0077","BK0188"],"gpt_icon":0},{"id":"2509054214","title":"暂停HPV疫苗中国市场供应?默沙东:预计年中逐步恢复常态","url":"https://stock-news.laohu8.com/highlight/detail?id=2509054214","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509054214?lang=zh_cn&edition=full","pubTime":"2025-02-05 18:40","pubTimestamp":1738752037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999002232.USD","LU0203345920.USD","LU0985320562.USD","SGXZ57979304.SGD","LU0320765646.SGD","BK4585","LU1941712264.USD","LU0211331839.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1974910355.USD","LU2361044865.SGD","LU1064131003.USD","LU1116320901.HKD","300122","LU0265550359.USD","SG9999001440.SGD","LU0006306889.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU1291159041.SGD","LU2361045086.USD","LU0266013472.USD","LU1066053197.SGD","LU1929549753.HKD","LU1934455277.USD","IE000M9KFDE8.USD","BK4533","LU1066051225.USD","IE00BN8TJ469.HKD","SG9999014567.USD","SG9999001176.USD","LU2023250504.SGD","BK4559","LU0106261372.USD","159646","LU1061106388.HKD","IE00BSNM7G36.USD","LU2112291526.USD","LU1037948541.HKD","LU2148510915.USD","BK0239","SG9999014559.SGD","YINN","BK0188","MRK","BK4588","LU1057294990.SGD","LU1571399168.USD","LU1328615791.USD"],"gpt_icon":0},{"id":"2509427183","title":"暂停向中国发货HPV疫苗?默沙东回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2509427183","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509427183?lang=zh_cn&edition=full","pubTime":"2025-02-05 15:13","pubTimestamp":1738739607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4516","LU0265550946.USD","300122","BK4533","LU1037948897.HKD","LU1064130708.USD","BK4585","LU0070302665.USD","LU0265550359.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU1929549753.HKD","LU0985320562.USD","IE00BLSP4452.SGD","LU1983299246.USD","LU1066051225.USD","LU1093756168.USD","LU1116320737.USD","LU2361044865.SGD","LU0965509010.AUD","SG9999014559.SGD","LU1571399168.USD","LU0320765646.SGD","SG9999002232.USD","159646","LU0208291251.USD","MRK","LU1066051498.USD","LU2468319806.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK0077","LU2106854487.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","LU0203345920.USD","LU2461242641.AUD","YINN","LU0965509101.SGD","BK0188","LU1934455277.USD","LU1057294990.SGD","LU2361044949.HKD","SGXZ57979304.SGD","SG9999013999.USD","BK0046","LU1116320901.HKD","SG9999014542.SGD","BK0196"],"gpt_icon":0},{"id":"2506329696","title":"智飞生物(300122)1月20日股东户数12.47万户,较上期减少3.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506329696","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506329696?lang=zh_cn&edition=full","pubTime":"2025-01-27 17:10","pubTimestamp":1737969008,"startTime":"0","endTime":"0","summary":"证券之星消息,近日智飞生物披露,截至2025年1月20日公司股东户数为12.47万户,较12月20日减少4110.0户,减幅为3.19%。在生物制品行业个股中,智飞生物股东户数高于行业平均水平,截至1月20日,生物制品行业平均股东户数为3.38万户。从股价来看,2024年12月20日至2025年1月20日,智飞生物区间跌幅为11.04%,在此期间股东户数减少4110.0户,减幅为3.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700022120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892862.HKD","BK0077","BK0239","LU1064131003.USD","LU2148510915.USD","300122","LU2580892789.USD","LU1328615791.USD","LU1064130708.USD","BK0188","BK0196","BK0046"],"gpt_icon":0},{"id":"2506325564","title":"智飞生物:截至2025年1月20日,公司普通股股东人数为124,674","url":"https://stock-news.laohu8.com/highlight/detail?id=2506325564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506325564?lang=zh_cn&edition=full","pubTime":"2025-01-27 16:30","pubTimestamp":1737966625,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物01月27日在投资者关系平台上答复投资者关心的问题。智飞生物董秘:您好,截至2025年1月20日,公司普通股股东人数为124,674,谢谢!投资者:请问公司会不会发业绩预告智飞生物董秘:您好,公司2024年度业绩预告请查阅发布在中国证监会指定信息披露网站巨潮资讯网上的《2024年度业绩预告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700020831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0188","LU2148510915.USD","LU2580892789.USD","BK0046","LU1328615791.USD","LU2580892862.HKD","LU1064131003.USD","BK0077","LU1064130708.USD","300122"],"gpt_icon":0},{"id":"2505865304","title":"智飞生物(300122.SZ)发预减,预计2024年度净利润18.56亿元–26.63亿元,同比下降67%-77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505865304","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505865304?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:20","pubTimestamp":1737728410,"startTime":"0","endTime":"0","summary":"智通财经APP讯,智飞生物 发布2024年度业绩预告,公司预计2024年度归属于上市公司股东的净利润18.56亿元–26.63亿元,同比下降67%-77%;扣除非经常性损益后的净利润18.21亿元–26.12亿元,同比下降67%-77%。公司部分产品的市场推广工作虽未达预期,但市场份额仍保持较高占有率,产品差异化竞争优势明显。公司将持续优化市场策略,以更好地适应市场趋势和客户需求,并严格把控经营风险,确保公司稳健发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300122"],"gpt_icon":0},{"id":"2505385996","title":"智飞生物:预计2024年全年扣非后净利润盈利18.21亿元至26.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505385996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505385996?lang=zh_cn&edition=full","pubTime":"2025-01-24 20:07","pubTimestamp":1737720430,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物发布业绩预告,预计2024年全年扣非后净利润盈利18.21亿元至26.12亿元。智飞生物2024年三季报显示,公司主营收入227.86亿元,同比下降41.98%;归母净利润21.51亿元,同比下降67.07%;扣非净利润21.43亿元,同比下降66.41%;其中2024年第三季度,公司单季度主营收入45.28亿元,同比下降69.46%;单季度归母净利润-8369.64万元,同比下降103.69%;单季度扣非净利润-8741.52万元,同比下降104.03%;负债率41.46%,财务费用5431.14万元,毛利率27.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400048387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122"],"gpt_icon":0},{"id":"2505856811","title":"智飞生物最新公告:预计2024年净利润同比下降67%-77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505856811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505856811?lang=zh_cn&edition=full","pubTime":"2025-01-24 19:49","pubTimestamp":1737719365,"startTime":"0","endTime":"0","summary":"智飞生物公告,预计2024年归属于上市公司股东的净利润为18.56亿元-26.63亿元,比上年同期下降67%-77%。公司表示,报告期内部分产品的市场推广工作虽未达预期,但市场份额仍保持较高占有率,产品差异化竞争优势明显。公司将持续优化市场策略,以更好地适应市场趋势和客户需求,并严格把控经营风险,确保公司稳健发展。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400047036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122"],"gpt_icon":0},{"id":"2502534108","title":"智飞生物:公司截至2024年12月31日的股东人数及其详情请关注并查阅公司定期报告披露的相关内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2502534108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502534108?lang=zh_cn&edition=full","pubTime":"2025-01-10 18:30","pubTimestamp":1736505011,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物01月10日在投资者关系平台上答复投资者关心的问题。谢谢智飞生物董秘:您好,公司截至2024年12月31日的股东人数及其详情请关注并查阅公司定期报告披露的相关内容,感谢关注!相关情况请以该公司公开发布的信息为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000034200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122","LU1064131003.USD","BK0239","BK0188","LU1064130708.USD","BK0077","BK0046","BK0196","LU2148510915.USD","LU2580892789.USD","LU2580892862.HKD","LU1328615791.USD"],"gpt_icon":0},{"id":"2502858550","title":"智飞生物:公司的员工持股计划在正常存续中","url":"https://stock-news.laohu8.com/highlight/detail?id=2502858550","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502858550?lang=zh_cn&edition=full","pubTime":"2025-01-10 17:24","pubTimestamp":1736501040,"startTime":"0","endTime":"0","summary":"有投资者向智飞生物提问, 你好,董秘,请问贵公司的员工持股计划还在续存中吗?公司回答表示,您好,公司的员工持股计划在正常存续中,谢谢!\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-01-10/doc-ineentrt5449183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2148510915.USD","LU2580892862.HKD","BK0077","BK0196","300122","LU1064130708.USD","BK0188","LU2580892789.USD","LU1064131003.USD","BK0046","LU1328615791.USD","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1740928222039,"stockEarnings":[{"period":"1week","weight":-0.0652},{"period":"1month","weight":0.0419},{"period":"3month","weight":-0.1398},{"period":"6month","weight":0.0968},{"period":"1year","weight":-0.513},{"period":"ytd","weight":-0.0456}],"compareEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":0.0216},{"period":"3month","weight":-0.0017},{"period":"6month","weight":0.1684},{"period":"1year","weight":0.1014},{"period":"ytd","weight":-0.0092}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆智飞生物制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"123312人(较上一季度减少1.09%)","perCapita":"11469股","listingDate":"2010-09-28","address":"重庆市江北区庆云路1号50层","registeredCapital":"239378万元","survey":" 重庆智飞生物制品股份有限公司是一家从事疫苗、生物制品的研发、生产和销售的公司;公司的主要产品包括预防流脑、宫颈癌、肺炎、轮状病毒等传染病的疫苗产品,也涵盖提供结核感染诊断、预防、治疗有效解决方案的药品。公司自成立以来,一贯注重研发与技术创新,通过十余年稳步增长的研发投入和持续深入的研发活动,形成了行业较领先的研发技术能力,并为公司可持续发展提供了技术根基。先后参与了科技部“863计划”,“现代医学技术”项目,科技部重大新药创制,国家新药创制重大专项等20余项国家级,省部级项目。","listedPrice":37.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.3","shortVersion":"4.31.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"智飞生物,300122,智飞生物股票,智飞生物股票老虎,智飞生物股票老虎国际,智飞生物行情,智飞生物股票行情,智飞生物股价,智飞生物股市,智飞生物股票价格,智飞生物股票交易,智飞生物股票购买,智飞生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}